Figure 5.
PFS and OS stratified by LAG3. Kaplan-Meier survival curves stratified by LAG3high or LAG3low mRNA digital gene counts. PFS (A) and OS (B) for patients in the discovery cohort. PFS (C) and OS (D) for patients in the validation cohort. PFS (E) and OS (F) for patients in the combined discovery and validation cohorts. (G) OS for patients from the combined cohort with high expression of PD-L1 mRNA. (H) OS for PD-L1high cases in the combined cohort stratified by the LAG3high prognostic cutoff.

PFS and OS stratified by LAG3. Kaplan-Meier survival curves stratified by LAG3high or LAG3low mRNA digital gene counts. PFS (A) and OS (B) for patients in the discovery cohort. PFS (C) and OS (D) for patients in the validation cohort. PFS (E) and OS (F) for patients in the combined discovery and validation cohorts. (G) OS for patients from the combined cohort with high expression of PD-L1 mRNA. (H) OS for PD-L1high cases in the combined cohort stratified by the LAG3high prognostic cutoff.

Close Modal

or Create an Account

Close Modal
Close Modal